YOUNG KEVIN 4
4 · GILEAD SCIENCES INC · Filed Aug 14, 2017
Insider Transaction Report
Form 4
YOUNG KEVIN
EVP, Commercial Operations
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-08-10−910→ 4,712 total→ Common Stock (910 underlying) - Tax Payment
Common Stock
2017-08-10$72.70/sh−453$32,933→ 6,688 total - Exercise/Conversion
Common Stock
2017-08-10+910→ 7,141 total
Footnotes (2)
- [F1]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
- [F2]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.